The Impact of Triptan and Doxycycline on Neuroinflammatory Biomarkers in Acute Migraine

Withdrawn before enrolling · Not applicable

Conditions studied: Migraine Disorders, Headache, Migraine, Migraine, Migraine Headache, Migraine With Aura, Migraine Without Aura, Headache Disorders, Primary

In brief

The purpose of this study is to determine the effects of triptans and doxycycline on neuroinflammatory markers in acute migraine.

Key facts

Study ID

NCT01653522

Run by

The Cleveland Clinic

People needed

0

Starts

2012-07-01

Expected to finish

2014-07-01

Last updated by the study team

2016-12-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Clinical diagnosis of migraine with or without aura that fulfill the 2nd Edition of The International Headache Classification (ICHD-II) criteria
• Active prescription for an oral triptan medication to abort acute migraines

You may not qualify if…

• Tetracycline group or other anti-inflammatory medication use in the preceding three months
• Pregnant

Where it is running

• Cleveland Clinic — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.